Drugs News and Research

RSS

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

BioWorld Today recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.

11 Dec 2009

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).

11 Dec 2009

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) approved Cequent's first IND (investigational new drug) application yesterday.

10 Dec 2009

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

"Flu vaccine shortages in developing nations may destabilize global security should the H1N1 [swine flu] virus become more deadly … David Heymann, a former deputy head of the World Health Organization" said Monday, Bloomberg reports.

10 Dec 2009

ARTs safe without routine lab tests, Lancet study finds

A Lancet study published online Tuesday validates the safety of administering first-line antiretroviral therapy (ART) to patients with HIV without routine toxicity and efficacy lab tests, "[b]ut tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment," HealthDay/U.S. News & World Report reports. Patients in Africa "often receive [HIV] drug treatment ... without routine laboratory monitoring," according to the article.

10 Dec 2009

Pelosi: Depending on Senate, House could work part of Christmas week

CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis -- a report not expected before next week -- that includes the most recent round of proposals to the bill they are considering.

10 Dec 2009

AFP examines insecticide resistance's effect on malaria fight in Nigeria

Agence France-Presse examines the increase in insecticide-resistant mosquitoes in Nigeria - "the latest threat to combating malaria" in the country. "Nigeria, Africa's most populous country, contributes more than a quarter of the one million malaria deaths in Africa, according to official statistics," AFP writes.

10 Dec 2009

Drug importation takes center stage on Senate floor

Debate on a proposal that would make it easier to bring prescription drugs into the country from abroad is taking center stage on the Senate floor as part of the health care reform debate.

10 Dec 2009

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.

10 Dec 2009

China Yongxin Pharmaceuticals reports financial results for third-quarter ended September 30, 2009

China Yongxin Pharmaceuticals, Inc., a leading pharmaceutical distributor and chain drugstore operator, today announced financial results for the third quarter ended September 30, 2009.

10 Dec 2009

First Edition: December 10, 2006

Today's headlines reflect Democrats' optimism surrounding the tentative agreement reached in the Senate just as questions about its specifics emerge.

10 Dec 2009

Event proceeds to benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare

Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.

10 Dec 2009

eHealth data identifies average premiums for non-group family health insurance plans in 46 states

eHealth, Inc., the leading online source of health insurance for individuals, families and small businesses, today released data from approximately 84,000 individually purchased, non-group, major medical family health insurance policies that were active in February of 2009.

10 Dec 2009

Cell transplants may yield new therapies for dementia patients

Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.

10 Dec 2009

RushCard introduces free prescription drug discount program

While lawmakers debate over proposals to make healthcare more affordable, RushCard is doing its part to lessen the burden for its cardholders by introducing a free prescription drug discount program.

10 Dec 2009

German researchers study target-oriented methods for children with brain tumor

Brain tumors are the primary cause of cancer mortality in children. Even if a cure is possible, young patients often suffer tremendously from the stressful treatment which can be harmful to the developing brain.

10 Dec 2009

Order Online Drugs announces the launch of OrderOnlineDrugs.com

Order Online Drugs Inc. is proud to announce the launch of OrderOnlineDrugs.com (www.orderonlinedrugs.com), a next generation online Canadian pharmacy that offers brand name prescription drugs at significantly lower prices compared to local drug stores.

10 Dec 2009

EC grants orphan drug designation for MP4CO for treating sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that the European Commission (EC) has granted orphan medicinal product designation for MP4CO for the treatment of sickle cell disease.

10 Dec 2009

Studies raise questions about the role and responsibilities of patients on medication safety

In a new study to asses patient awareness of medications prescribed during a hospital visit, 44% of patients believed they were receiving a medication they were not, and 96% were unable to recall the name of at least one medication that they had been prescribed during hospitalization. These findings are published today in the Journal of Hospital Medicine.

10 Dec 2009

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

Although lidocaine is most often used as a local anesthetic, low doses of lidocaine given intravenously can help to control pain after common ambulatory surgery procedures, suggests a study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

10 Dec 2009

Drugs News and Research

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

ARTs safe without routine lab tests, Lancet study finds

Pelosi: Depending on Senate, House could work part of Christmas week

AFP examines insecticide resistance's effect on malaria fight in Nigeria

Drug importation takes center stage on Senate floor

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

China Yongxin Pharmaceuticals reports financial results for third-quarter ended September 30, 2009

First Edition: December 10, 2006

Event proceeds to benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare

eHealth data identifies average premiums for non-group family health insurance plans in 46 states

Cell transplants may yield new therapies for dementia patients

RushCard introduces free prescription drug discount program

German researchers study target-oriented methods for children with brain tumor

Order Online Drugs announces the launch of OrderOnlineDrugs.com

EC grants orphan drug designation for MP4CO for treating sickle cell disease

Studies raise questions about the role and responsibilities of patients on medication safety

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News